| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/21/2000 | WO2000054788A1 Pharmaceutical composition for medical and veterinary use for regenerating intestinal flora in diarrhoea or dyspeptic syndrome |
| 09/21/2000 | WO2000054780A2 Corticosteroid formulation |
| 09/21/2000 | WO2000054769A1 Protease inhibitors |
| 09/21/2000 | WO2000054765A1 Method of treating eating disorders |
| 09/21/2000 | WO2000054728A2 Use of a bacterial composition for treating periodontal diseases |
| 09/21/2000 | WO2000054604A1 Method of using anti-phospholipase a2 antibodies to enhance growth or improve feed efficiency |
| 09/21/2000 | WO2000040225A3 Inhibition of tnf activity |
| 09/21/2000 | WO2000027868A3 Connective tissue growth factor (ctgf) and methods of use |
| 09/21/2000 | WO2000010551A3 Methods of using and compositions comprising dopamine reuptake inhibitors |
| 09/21/2000 | DE19911510A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation |
| 09/21/2000 | DE19911509A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation |
| 09/21/2000 | DE19911371A1 Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen Drugs for the treatment of functional disorders and diseases of the lower intestinal tracts, especially of associated abdominal visceral pain |
| 09/21/2000 | CA2675416A1 Lipoxin compounds and their use |
| 09/21/2000 | CA2367340A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
| 09/21/2000 | CA2366195A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides |
| 09/21/2000 | CA2366174A1 Human colon cancer associated gene sequences and polypeptides |
| 09/21/2000 | CA2366130A1 Human cancer associated gene sequences and polypeptides |
| 09/21/2000 | CA2365214A1 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 09/21/2000 | CA2364739A1 Regulators of intracellular phosphorylation |
| 09/21/2000 | CA2364637A1 50 human secreted proteins |
| 09/21/2000 | CA2364635A1 47 human secreted proteins |
| 09/21/2000 | CA2364629A1 Human lung cancer associated gene sequences and polypeptides |
| 09/21/2000 | CA2364590A1 Human prostate cancer associated gene sequences and polypeptides |
| 09/21/2000 | CA2361819A1 Amide derivatives |
| 09/21/2000 | CA2361770A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 09/21/2000 | CA2361503A1 Corticosteroid formulation |
| 09/21/2000 | CA2361277A1 49 human secreted proteins |
| 09/20/2000 | EP1036191A2 Method for identifying ihbitors of g-protein coupled receptor hibef51 |
| 09/20/2000 | EP1036073A1 (benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties |
| 09/20/2000 | EP1035870A1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 09/20/2000 | EP1035868A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation |
| 09/20/2000 | EP1035857A1 Oral antioxidant preparation comprising selenium and reduced glutathione |
| 09/20/2000 | EP1035848A1 Substituted alkanohydroxamic acids and method of reducing tnf-alpha levels |
| 09/20/2000 | EP1035824A1 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 09/20/2000 | CN1267296A Barbituric acid derivs with antimetastatic and antitumor activity |
| 09/20/2000 | CN1267286A 2-{3-[4-(2-t-butyl-6-trifluoromethylpyridin-4-yl) piperazin-1-yl] propylmercapto} pyrimidin-4-ol-fumarate |
| 09/20/2000 | CN1266689A Gel for treating tooth anaphylactia and occulation facing |
| 09/20/2000 | CN1266688A 活性双歧杆菌胶囊 Active Bifidobacterium Capsules |
| 09/20/2000 | CN1266680A Application of ursolic acid in medicine for treating viral hepatitis |
| 09/20/2000 | CN1056611C Pyrazolo and pyrrolopyridines, their use and intermidiates for preparing same |
| 09/20/2000 | CN1056608C Pseudodipeptide product having imidazole group and applications |
| 09/20/2000 | CN1056607C Tricyclic pyrazole derivs. |
| 09/20/2000 | CN1056605C Compounds as selective human NK 3-receptor antagonists and their use |
| 09/20/2000 | CN1056533C 'Baizhong' plaster for children |
| 09/20/2000 | CN1056530C Chinese medicine composition for treating habitual constipation |
| 09/20/2000 | CN1056523C Anti-diarrhea traditional Mongolian medicine-manna-like powder for children |
| 09/20/2000 | CN1056520C Anti-senility hypolpemic Chinese medicine liquor |
| 09/20/2000 | CN1056513C External use drug for treatment of odontopathy |
| 09/19/2000 | US6121326 Antiinflammatory agents; antiallergens; analgesics; antiemetics |
| 09/19/2000 | US6121317 Gibberellins (including gibberellins A3 and A7) used in ulcer or wound healing |
| 09/19/2000 | US6121316 2-cyano-3,5-dihydroxyhex-2-enecarboxamide derivatives |
| 09/19/2000 | US6121305 5,5'-dihydroxy-4,4'-bipyrazole compounds of given formula; free radical scavenger; use to treat cerebral ischemia, heart disease, carcinoma, aging, inflammation or digestive system disease, or in detection of an active oxygen or free radicals |
| 09/19/2000 | US6121304 Pentafluorobenzenesulfonamides and analogs |
| 09/19/2000 | US6121279 Phosphodiesterase inhibitor for treating respiratory system disorders |
| 09/19/2000 | US6121274 Phosphodiesterase inhibitor for treatment of respiratory system disorders |
| 09/19/2000 | US6121272 Bidentate metalloprotease inhibitors |
| 09/19/2000 | US6121259 Olanzapine-N-oxide compositions and methods |
| 09/19/2000 | US6121258 For treatment of arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease |
| 09/19/2000 | US6121253 Prostaglandin conjugates for treating or preventing bone disease |
| 09/19/2000 | US6121250 Emulsified liquid agent mainly consisting of water-soluble high-molecular weight compound and electrolyte contains silicone-containing antifoam agent |
| 09/19/2000 | CA2053242C Protease inhibitor |
| 09/15/2000 | CA2301679A1 Medication for treatment of functional distrubances or illnesses of the lower intestinal tract, particularly abdominal visceral pain which accompanies them |
| 09/14/2000 | WO2000053608A1 Pyridopyranoazepine derivatives, preparation and therapeutic use |
| 09/14/2000 | WO2000053604A1 Carbamoyl tetrahydropyridine derivatives |
| 09/14/2000 | WO2000053602A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 09/14/2000 | WO2000053596A2 Imidazole compounds as histamine h3 ligands |
| 09/14/2000 | WO2000053592A1 Osteogenesis promoters |
| 09/14/2000 | WO2000053581A2 Heterocyclic compounds having antitumor activity |
| 09/14/2000 | WO2000053572A1 Biphenyl derivatives as antagonists of the neurokinine-1 receptor |
| 09/14/2000 | WO2000053562A1 Retinoid antagonists and use thereof |
| 09/14/2000 | WO2000053232A1 Matriptase, a serine protease and its applications |
| 09/14/2000 | WO2000053202A1 Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses |
| 09/14/2000 | WO2000053201A1 Lactic acid bacteria strains capable of preventing diarrhoea |
| 09/14/2000 | WO2000053200A1 Lactobacillus strains preventing diarrhoea pathogenic bacteria |
| 09/14/2000 | WO2000053178A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 09/14/2000 | WO2000053162A1 Controlled-release compositions of betahistine |
| 09/14/2000 | WO2000053157A1 Improved powdery pharmaceutical compositions for inhalation |
| 09/14/2000 | WO2000053030A2 Pet food product with coconut endosperm fibre |
| 09/14/2000 | WO2000037422A3 Ion channel modulating agents |
| 09/14/2000 | WO2000035430A3 Homer a new target of treating psychiatric disorders |
| 09/14/2000 | WO2000031263A3 Gtpase associated proteins |
| 09/14/2000 | WO2000023599A3 Human proteins involved in endoplasmic reticulum protein degradation |
| 09/14/2000 | CA2367113A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 09/14/2000 | CA2366642A1 Carbamoyl tetrahydropyridine derivatives |
| 09/14/2000 | CA2366615A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 09/14/2000 | CA2364440A1 Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses |
| 09/14/2000 | CA2364435A1 Lactobacillus strains preventing diarrhoea pathogenic bacteria |
| 09/14/2000 | CA2364226A1 Controlled-release compositions of betahistine |
| 09/14/2000 | CA2362670A1 Matriptase, a serine protease and its applications |
| 09/14/2000 | CA2362319A1 Imidazole compounds as histamine h3 ligands |
| 09/13/2000 | EP1035115A1 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists |
| 09/13/2000 | EP1034790A2 HIV therapy |
| 09/13/2000 | EP1034788A1 Lactic acid bacteria strains capable of preventing diarrhea |
| 09/13/2000 | EP1034787A1 Lactobacillus strains preventing diarrhea caused by pathogenic bacteria |
| 09/13/2000 | EP1034786A1 Method for delivering direct feed microorganisms to poultry in ovo |
| 09/13/2000 | EP1034264A1 Splice variants for human 5-ht 4? serotonin receptor and their applications, in particular for screening |
| 09/13/2000 | EP1034164A1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 09/13/2000 | EP1034162A1 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
| 09/13/2000 | EP1033993A1 Use of the e.coli strain dsm 6601 for treating diarrhoea in veterinary medicine |
| 09/13/2000 | EP1033983A1 Cyclic amino acid derivatives as cell adhesion inhibitors |